Pharmadons: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharmadons
Largest movements
- Receivables within one year +€90,261
up €90,261 (+24.7%), from €365,228 to €455,489
of which Other amounts receivable: +€85,231
- Stocks and contracts -€19,617
down €19,617 (-19.4%), from €101,210 to €81,593
- Cash -€11,247
down €11,247 (-18.4%), from €61,130 to €49,883
mainly Contributions, distributions and other (-€300,000) and Receivables within one year (-€90,261)
- Profit (loss) carried forward -€309,746
down €309,746 (-79.9%), from €387,466 to €77,720
- Other debts +€296,346
up €296,346 (+8110.0%), from €3,654 to €300,000
- Trade debts +€50,857
up €50,857 (+59.7%), from €85,139 to €135,996
- Short-term financial debts +€28,379
up €28,379, from €0 to €28,379
- Debts after one year +€7,283
up €7,283 (+125.1%), from €5,822 to €13,105
of which Other amounts payable: +€13,105
- Gross operating margin -€39,478
down €39,478 (-26.4%), from €149,579 to €110,101
- Staff costs -€32,265
down €32,265 (-21.4%), from €150,691 to €118,426
- Taxes -€5,434
down €5,434, from €0 to -€5,434
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €534,160 | €608,875 | +€74,715 | +14.0% |
| Fixed assets | 21/28 | €4,955 | €14,621 | +€9,666 | +195.1% |
| Tangible fixed assets | 22/27 | €4,955 | €10,121 | +€5,166 | +104.3% |
| Plant, machinery and equipment | 23 | €0 | €4,937 | +€4,937 | |
| Furniture and vehicles | 24 | €4,955 | €5,184 | +€230 | +4.6% |
| Financial fixed assets | 28 | - | €4,500 | +€4,500 | |
| Current assets | 29/58 | €529,205 | €594,254 | +€65,048 | +12.3% |
| Stocks and contracts in progress | 3 | €101,210 | €81,593 | -€19,617 | -19.4% |
| Stocks | 30/36 | €101,210 | €81,593 | -€19,617 | -19.4% |
| Amounts receivable within one year | 40/41 | €365,228 | €455,489 | +€90,261 | +24.7% |
| Trade receivables | 40 | €45,795 | €50,825 | +€5,030 | +11.0% |
| Other amounts receivable | 41 | €319,433 | €404,664 | +€85,231 | +26.7% |
| Cash at bank and in hand | 54/58 | €61,130 | €49,883 | -€11,247 | -18.4% |
| Deferred charges and accrued income | 490/1 | €1,638 | €7,289 | +€5,652 | +345.1% |
| Total equity and liabilities | 10/49 | €534,160 | €608,875 | +€74,715 | +14.0% |
| Equity | 10/15 | €407,926 | €98,180 | -€309,746 | -75.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €387,466 | €77,720 | -€309,746 | -79.9% |
| Amounts payable | 17/49 | €126,234 | €510,695 | +€384,461 | +304.6% |
| Amounts payable after more than one year | 17 | €5,822 | €13,105 | +€7,283 | +125.1% |
| Financial debts | 170/4 | €5,822 | €0 | -€5,822 | -100.0% |
| Other amounts payable | 178/9 | - | €13,105 | +€13,105 | |
| Amounts payable within one year | 42/48 | €120,412 | €497,590 | +€377,178 | +313.2% |
| Current portion of amounts payable after more than one year | 42 | €14,178 | €18,329 | +€4,151 | +29.3% |
| Financial debts | 43 | €0 | €28,379 | +€28,379 | |
| Credit institutions | 430/8 | €0 | €28,379 | +€28,379 | |
| Trade debts | 44 | €85,139 | €135,996 | +€50,857 | +59.7% |
| Suppliers | 440/4 | €85,139 | €135,996 | +€50,857 | +59.7% |
| Taxes, remuneration and social security | 45 | €17,441 | €14,886 | -€2,555 | -14.7% |
| Taxes | 450/3 | €6,930 | €0 | -€6,930 | -100.0% |
| Remuneration and social security | 454/9 | €10,511 | €14,886 | +€4,374 | +41.6% |
| Other amounts payable | 47/48 | €3,654 | €300,000 | +€296,346 | +8110.0% |
| Remuneration, social security and pensions | 62 | €150,691 | €118,426 | -€32,265 | -21.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,856 | €2,068 | +€212 | +11.4% |
| Other operating charges | 640/8 | €392 | €416 | +€25 | +6.3% |
| Gross operating margin | 9900 | €149,579 | €110,101 | -€39,478 | -26.4% |
| Operating profit (loss) | 9901 | -€3,359 | -€10,809 | -€7,450 | -221.8% |
| Financial income | 75/76B | €3 | €67 | +€64 | +2505.1% |
| Recurring financial income | 75 | €3 | €67 | +€64 | +2505.1% |
| Financial charges | 65/66B | €3,839 | €4,439 | +€600 | +15.6% |
| Recurring financial charges | 65 | €3,839 | €4,439 | +€600 | +15.6% |
| Profit (loss) for the period before taxes | 9903 | -€7,195 | -€15,180 | -€7,985 | -111.0% |
| Income taxes | 67/77 | €0 | -€5,434 | -€5,434 | |
| Profit (loss) for the period | 9904 | -€7,195 | -€9,746 | -€2,551 | -35.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,195 | -€9,746 | -€2,551 | -35.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.